Lucid Diagnostics Inc. is a commercial-stage medical diagnostics company focused on cancer prevention, and subsidiary of PAVmed Inc. (Nasdaq: PAVM) Lucid believes EsoGuard is the missing element – the first and only commercially available diagnostic test capable of serving as a widespread screening tool to prevent esophageal precancer. In nearly all cases, EAC has increased 500 percent over the past four decades, while the incidences of other common cancers have declined or